This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...